Vimarsana
Biggest News Aggregation in the World

Prosight Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prosight Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prosight Capital Today - Breaking & Trending Today

Did The Smart Money Get Iovance Biotherapeutics, Inc. (IOVA) Right? - Vimarsana News

Did The Smart Money Get Iovance Biotherapeutics, Inc. (IOVA) Right?

Technology stocks had a lousy start to 2022. QQQ lost 9% of its value in January. Pandemic winners are getting crushed while energy stocks are surging.

Was The Smart Money Right About Revlon Inc (REV)? - Vimarsana News

Was The Smart Money Right About Revlon Inc (REV)?

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file by the SEC.

Is Galapagos NV (GLPG) A Good Stock To Buy? - Vimarsana News

Is Galapagos NV (GLPG) A Good Stock To Buy?

In this article we will take a look at whether hedge funds think Galapagos NV (NASDAQ:GLPG) is a good investment right now.

Hedge Funds Are Buying KalVista Pharmaceuticals, Inc. (KALV) - Vimarsana News

Hedge Funds Are Buying KalVista Pharmaceuticals, Inc. (KALV)

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Hedge Funds Are Piling Into Accolade, Inc. (ACCD) - Vimarsana News

Hedge Funds Are Piling Into Accolade, Inc. (ACCD)

In this article we are going to use hedge fund sentiment as a tool and determine whether Accolade, Inc. (NASDAQ:ACCD) is a good investment right now.